Clinical Study of Umbilical Cord Tissue Mesenchymal Stem Cells (UC-MSC) for Treatment of Osteoarthritis
Status: Withdrawn prior to enrolment
Phase of Trial: Phase I/II
Latest Information Update: 02 May 2017
Price : $35 *
At a glance
- Drugs Cord blood stem cell therapy (Primary) ; Cord blood stem cell therapy (Primary)
- Indications Osteoarthritis
- Focus Adverse reactions
- Sponsors Translational Biosciences
- 26 Apr 2017 Status changed from active, no longer recruiting to withdrawn prior to enrolment.
- 17 Oct 2016 Planned End Date changed from 1 Mar 2017 to 1 Aug 2019.
- 17 Oct 2016 Planned primary completion date changed from 1 Sep 2016 to 1 Nov 2018.